Task: Answer the multiple choice question.
Query: Which drug exhibits a -35.781% human ether-à-go-go related gene (hERG) inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a O=C(Nc1cccnc1)c1cc(S(=O)(=O)N2CCOCC2)ccc1Br
b Cc1ccc(C(=O)N(CC#N)CC#N)cc1C
Answer: a. O=C(Nc1cccnc1)c1cc(S(=O)(=O)N2CCOCC2)ccc1Br
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
O=C(Nc1cccnc1)c1cc(S(=O)(=O)N2CCOCC2)ccc1Br
O=C(Nc1cccnc1)c1cc(S(=O)(=O)N2CCOCC2)ccc1Br
2-bromo-5-morpholin-4-ylsulfonyl-N-pyridin-3-ylbenzamide